REGISTERED
on 03 Oct 2023
Last Applicant/ Owned by
Serial Number
79346405 filed on 09th Jun 2022
Registration Number
7178487 registered on 03rd Oct 2023
Correspondent Address
Susan Fentress
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
BARRIOLIDES
Scientific and technological services and research and design relating thereto, namely, scientific research in the field of pharmaceutical studies research, scientific research in new pharmaceutical design services, medical and pharmacological research services, drug discovery services, pharmaceutical drug development services, pharmaceutical research and development; industrial analysis and resea Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Scientific and technological services and research and design relating thereto, namely, scientific research in the field of pharmaceutical studies research, scientific research in new pharmaceutical design services, medical and pharmacological research services, drug discovery services, pharmaceutical drug development services, pharmaceutical research and development; industrial analysis and research services, namely, pharmaceutical analysis and pharmaceutical research
Class [005]
Pharmaceutical Products
Pharmaceutical and veterinary preparations to improve function of membranes in the body; pharmaceutical and veterinary preparations to improve function of membranes in the lung; pharmaceutical and veterinary preparations to enhance the epithelial barrier; pharmaceutical and veterinary preparations to enhance the airway epithelial barrier; pharmaceutical and veterinary preparations to inhibit inflammation; pharmaceutical and veterinary preparations for the treatment of a disease or condition that is caused by a defect in epithelial cells or tissue; pharmaceutical and veterinary preparations for the treatment of a disease or condition that benefits from enhancement or restoration of epithelial barrier function; pharmaceutical and veterinary preparations for the treatment of a disease or condition of epithelial tissue in the respiratory tract; pharmaceutical and veterinary preparations for the treatment of epithelial dysfunction; pharmaceutical and veterinary preparations for the treatment of human airway epithelial cells; pharmaceutical and veterinary preparations for the treatment of chronic respiratory diseases; pharmaceutical and veterinary preparations for the treatment of viral airways diseases; pharmaceutical and veterinary preparations for the treatment of an airways disease; pharmaceutical and veterinary preparations for the treatment of asthma; pharmaceutical and veterinary preparations for the treatment of chronic obstructive pulmonary disease (COPD); pharmaceutical and veterinary preparations for the treatment of cystic fibrosis; pharmaceutical and veterinary preparations for the treatment of non-cystic fibrosis bronchiectasis; pharmaceutical and veterinary preparations for the treatment of chronic rhinosinusitis; pharmaceutical and veterinary preparations for the treatment of diffuse panbronchiolitis (DPB); pharmaceutical and veterinary preparations for the treatment of chronic bronchitis; pharmaceutical and veterinary preparations for the treatment of bronchiolitis obliterans organizing pneumonia (BOOP); pharmaceutical and veterinary preparations for the treatment of infantile respiratory distress syndrome (IRDS); pharmaceutical and veterinary preparations for the treatment of bronchopulmonary dysplasia; pharmaceutical and veterinary preparations for the treatment of neuromuscular respiratory depression or failure; pharmaceutical and veterinary preparations for the treatment of pneumonia; pharmaceutical and veterinary preparations for the treatment of conditions caused by and associated with respiratory syncytial virus (RSV) and related viruses; pharmaceutical and veterinary preparations for the treatment of a disease or condition commonly associated with inflammation that benefits from enhancement or restoration of epithelial barrier function; pharmaceutical and veterinary preparations for the treatment of systemic inflammatory distress syndrome (SIRS); pharmaceutical and veterinary preparations for the treatment of adult respiratory distress syndrome (ARDS); pharmaceutical and veterinary preparations for the treatment of inflammatory bowel disease; pharmaceutical and veterinary preparations for the treatment of ulcerative colitis; pharmaceutical and veterinary preparations for the treatment of Crohn's disease; sanitary preparations for medical purposes; dietary supplements for human beings and animals
Class [001]
Chemical Products
Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; biological preparations for use in industry and science
Mark Details
Serial Number
No 79346405
Mark Type
No Service Mark
Attorney Docket Number
No 70060.001
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 30th Jan 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 08th Jan 2024 | FINAL DISPOSITION PROCESSED |
| 08th Jan 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| 03rd Jan 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 03rd Oct 2023 | REGISTERED-PRINCIPAL REGISTER |
| 03rd Oct 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 18th Jul 2023 | PUBLISHED FOR OPPOSITION |
| 18th Jul 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 28th Jun 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 18th Jun 2023 | REFUSAL PROCESSED BY IB |